News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
199,188 Results
Type
Article (5495)
Company Profile (52)
Press Release (193639)
Multimedia
Podcasts (12)
Webinars (7)
Section
Business (54077)
Career Advice (301)
Deals (10987)
Drug Delivery (27)
Drug Development (9804)
Employer Resources (28)
FDA (5338)
Job Trends (4624)
News (82246)
Policy (6191)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (1)
Academia (654)
Accelerated approval (5)
ADA (9)
Allergies (50)
Alliances (19164)
ALS (48)
Alzheimer's disease (430)
Antibody-drug conjugate (ADC) (64)
Approvals (5634)
Artificial intelligence (411)
ASCO (25)
Autoimmune disease (65)
Automation (54)
Bankruptcy (70)
Best Places to Work (4245)
BIO (20)
BIOSECURE Act (3)
Biosimilars (77)
Biotechnology (38)
Bladder cancer (53)
Brain cancer (13)
Breast cancer (148)
Cancer (1258)
Cardiovascular disease (121)
Career advice (273)
Career pathing (10)
CAR-T (59)
CDC (3)
Cell therapy (201)
Cervical cancer (22)
Clinical research (8952)
Collaboration (1023)
Compensation (140)
Complete response letters (16)
COVID-19 (543)
CRISPR (42)
C-suite (380)
Cystic fibrosis (27)
Data (1719)
Decentralized trials (2)
Denatured (8)
Depression (33)
Dermatology (36)
Diabetes (156)
Diagnostics (3518)
Digital health (41)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (132)
Drug pricing (30)
Drug shortages (4)
Duchenne muscular dystrophy (17)
Earnings (18669)
Editorial (8)
Employer resources (28)
Events (25849)
Executive appointments (413)
FDA (6772)
Frontotemporal dementia (1)
Funding (643)
Gene editing (65)
Generative AI (24)
Gene therapy (158)
GLP-1 (199)
Government (793)
Grass and pollen (2)
Guidances (170)
Healthcare (6252)
Hematology (27)
HIV (46)
Huntington's disease (6)
IgA nephropathy (12)
Immunology and inflammation (18)
Immuno-oncology (11)
Indications (67)
Infectious disease (642)
Inflammatory bowel disease (47)
Inflation Reduction Act (2)
Influenza (40)
Intellectual property (85)
Interviews (41)
IPO (4469)
IRA (5)
Job creations (539)
Job search strategy (214)
JPM (8)
Kidney cancer (3)
Labor market (17)
Layoffs (53)
Leadership (12)
Legal (1090)
Liver cancer (13)
Longevity (15)
Lung cancer (162)
Lymphoma (86)
Machine learning (32)
Management (13)
Manufacturing (530)
MASH (20)
Medical device (7559)
Medtech (7683)
Mergers & acquisitions (7151)
Metabolic disorders (299)
mRNA (32)
Multiple sclerosis (32)
NASH (1)
Neurodegenerative disease (103)
Neuropsychiatric disorders (11)
Neuroscience (762)
NextGen: Class of 2026 (2475)
Non-profit (1098)
Now hiring (8)
Obesity (105)
Opinion (76)
Ovarian cancer (30)
Pain (120)
Pancreatic cancer (65)
Parkinson's disease (86)
Partnered (18)
Patents (189)
Patient recruitment (160)
Peanut (18)
People (15362)
Pharmaceutical (8)
Pharmacy benefit managers (12)
Phase 1 (2194)
Phase 2 (3490)
Phase 3 (3791)
Pipeline (2848)
Policy (38)
Postmarket research (370)
Preclinical (1020)
Press Release (19)
Prostate cancer (80)
Psychedelics (4)
Radiopharmaceuticals (110)
Rare diseases (246)
Real estate (1787)
Recruiting (8)
Regulatory (5888)
Reports (14)
Research institute (678)
Resumes & cover letters (47)
Rett syndrome (9)
RNA editing (3)
RSV (21)
Schizophrenia (16)
Series A (112)
Series B (72)
Service/supplier (5)
Sickle cell disease (11)
Special edition (3)
Spinal muscular atrophy (53)
Sponsored (25)
Startups (866)
State (1)
Supply chain (62)
Tariffs (7)
The Weekly (4)
Vaccines (218)
Venture capital (15)
Weight loss (67)
Women's health (74)
Worklife (4)
Date
Last 7 days (112)
Last 30 days (581)
Last 365 days (8505)
2026 (4686)
2025 (8748)
2024 (10710)
2023 (11848)
2022 (17764)
2021 (18933)
2020 (19035)
2019 (16886)
2018 (12215)
2017 (9609)
2016 (8957)
2015 (9780)
2014 (7113)
2013 (6083)
2012 (6447)
2011 (6306)
2010 (4995)
Location
Africa (157)
Alabama (25)
Alaska (2)
Arizona (112)
Arkansas (6)
Asia (10311)
Australia (1368)
California (3661)
Canada (1184)
China (352)
Colorado (237)
Connecticut (153)
Delaware (145)
Europe (27256)
Florida (690)
Georgia (238)
Hawaii (2)
Idaho (44)
Illinois (571)
India (55)
Indiana (388)
Iowa (10)
Japan (172)
Kansas (38)
Kentucky (24)
Louisiana (25)
Maine (33)
Maryland (407)
Massachusetts (2090)
Michigan (206)
Minnesota (403)
Mississippi (5)
Missouri (91)
Montana (19)
Nebraska (12)
Nevada (51)
New Hampshire (52)
New Jersey (1245)
New Mexico (18)
New York (755)
North Carolina (755)
North Dakota (9)
Northern California (1669)
Ohio (200)
Oklahoma (12)
Oregon (18)
Pennsylvania (761)
Puerto Rico (4)
Rhode Island (30)
South America (300)
South Carolina (69)
South Dakota (1)
Southern California (1512)
Tennessee (86)
Texas (635)
United States (14344)
Utah (132)
Vermont (2)
Virginia (96)
Washington D.C. (20)
Washington State (220)
West Virginia (2)
Wisconsin (107)
Wyoming (1)
199,188 Results for "ion solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AbTherx Expands Platform and Leadership Team to Unlock Antibody Discovery for Multispecifics, Enzymes, GPCRs, and Ion Channels
June 10, 2026
·
4 min read
Press Releases
Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model
Data Presented at Epilepsy Foundation Pipeline Conference Demonstrated Significant Reduction in Epileptiform Activity: KIO-300 is the active pharmaceutical ingredient of KIO-301, Kiora’s ongoing Phase 2 clinical program in vision restoration in patients with gene mutation-agnostic Retinitis Pigmentosa
June 18, 2026
·
4 min read
Press Releases
SurGenTec® Secures FDA Clearance for ION-C™ Facet Fixation System — Designed to Support Fusion While Preserving Alignment
January 21, 2026
·
3 min read
Press Releases
Detect-ION Launches Collaborative Project to Develop Breath-Based Diagnostics for Pneumonia-Causing Pathogens
December 16, 2025
·
4 min read
Press Releases
HUYABIO International Presents Positive Clinical Results from HBI-3000, a Novel Multi-ion Channel Blocker for Acute Atrial Fibrillation
January 6, 2026
·
2 min read
Press Releases
The National Proton Therapy Center of Portugal will be equipped with two IBA Proteus®ONE solutions
June 30, 2026
·
4 min read
Press Releases
Ionis receives U.S. FDA Breakthrough Therapy designation for ION582 in Angelman syndrome
September 9, 2025
·
5 min read
Press Releases
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
September 25, 2025
·
1 min read
Press Releases
QurAlis Confirms Signal of Target Engagement in ALS Patients in Phase 1 Clinical Trial of QRL-101, a Potentially Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener
December 29, 2025
·
4 min read
Press Releases
IBA signs contract with a major U.S. academic medical center to install two Proteus®ONE proton therapy solutions
June 8, 2026
·
2 min read
1 of 19,919
Next
